Classification of CD4+ T Helper Cell Clones in Human Melanoma

Abstract We have previously described the generation of tumor-infiltrating lymphocyte (TIL) clones from renal cell cancer by solid-phase anti-CD3 antibody activation and expansion in 100 IU/ml IL-2 plus irradiated allogeneic B cells. These culture conditions did not select for a particular T cell subset. Using these culture conditions, we report here the generation of 66 CD4 + and 36 CD8 + TIL clones from five patients with melanoma. Eighty-five percent of the CD4 + TIL clones were not cytolytic ( + clones showed strong ARL activity (> 30% lysis). Clones were further tested for production of IL-2, IL-4, and IFN-γ after activation for 48 hr by solid-phase anti-CD3. CD8 + clones produced significant amounts of IFN-γ little IL-2, and no IL-4. CD4 + clones were classified as Th0, Th1, or Th2, analogous to the classification of T helper cells in the mouse. Sixty-six percent existed as Th0, producing IL-2, IL-4, and IFN-γ. Only 15% existed as Th1, producing IL-2 and IFN-γ, and 19% as Th2, producing IL-4 but no IL-2 or IFN-γ. In all cases, unstimulated clones or clones stimulated with the allogeneic B cell line did not produce detectable amounts of cytokines. Solid-phase anti-CD3 activation was compared to activation with autologous melanoma cells. Five of nine CD8 + clones produced low amounts of IL-2 ( 6 cells) in response to autologous tumor, but none of the CD8 clones produced IFN-γ or IL-4. Also, 5/7 Th0 clones from one patient produced similar amounts of IL-2 after stimulation with anti-CD3 or autologous tumor. The other two clones produced only 10% or less of the amount produced in response to anti-CD3. No IL-4 or IFN-γ could be detected in response to autologous tumor. In contrast, none of the 12 T helper clones from two other patients produced any cytokines after stimulation with autologous tumor cells. Together these data suggest that the T cell infiltrate in melanoma consists primarily of IL-2-producing Th0 cells, but few of those are triggered by autologous tumor cells.